Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
BTIG reduced its price target for Roblox Corp. to $141 from $174 while maintaining a Buy rating ahead of the company’s fourth-quarter results due on February 5. The firm modestly raised bookings estimates for late-2025 and 2026, pointing to a split between weaker concurrent-user metrics and relatively stronger payer and monetization signals. Other …
Barclays initiated coverage of BridgeBio Pharma (BBIO) with an Overweight rating and an $80.00 price target, noting the company’s diversified late-stage portfolio and potential to scale. The move follows strong Attruby sales and preliminary revenue figures for 2025 and coincides with BridgeBio’s $550 million convertible note offering due 2033.
BofA Securities cut Plains All American (PAA) from Neutral to Underperform and kept a $19.00 price target, pointing to constrained Permian Basin production growth, a flat EBITDA forecast through the 2030s, and reduced upside from a lower FERC PPI adder. The bank also downgraded Plains GP Holdings on similar grounds.
Barclays has opened coverage on Bloom Energy (NYSE: BE) with an Equalweight rating and a $153 price objective. The bank cites the company’s rapid site commissioning, falling costs and average selling prices, and recent contract validations as demand drivers for its solid-oxide fuel cell technology, while warning that current market valuation alread…
BofA Securities upgraded Microchip Technology from Neutral to Buy and increased its price target to $95 from $78, citing improving recovery momentum and clearer visibility into demand. The firm boosted its CY26 and CY27 EPS estimates, highlighted the company’s significant industrial and aerospace exposure, and pointed to data-center-facing products…
BofA Securities has initiated coverage of Celestica (NYSE: CLS) with a Buy rating and a $400 price target, highlighting the company’s position in white-box switching and custom ASIC accelerated servers. The firm expects fiscal 2027 to be a standout year as new programs ramp, and bases its valuation on a 32x multiple of calendar 2027 estimated EPS o…
BofA Securities downgraded Plains GP Holdings, L.P. (PAGP) from Neutral to Underperform while keeping a $19.00 price target, pointing to concerns about the long-term trajectory of Permian Basin oil production and regulatory changes that reduce inflation-linked upside. The note also outlines infrastructure and capital-spend scenarios for Plains All …
BofA Securities upgraded Texas Instruments from Underperform to Neutral and raised its price target to $235 from $185 after the company reported in-line fourth-quarter results and provided a first-quarter revenue outlook that exceeded expectations. The bank cited improving backlog and order trends, robust data center demand, and potential for susta…
Morgan Stanley increased its price target on RTX Corp. to $235 from $215 and kept an Overweight rating, pointing to the company’s positioning for continued revenue expansion, margin improvement and potential re-rating by the market. The upgrade follows a robust fourth-quarter performance and a string of price-target adjustments by other brokers, al…
Baird raised its price objective for Texas Instruments to $225 from $195 while maintaining an Outperform rating, pointing to an above-seasonal, unit-driven first-quarter outlook and the company’s exposure to direct customers as reasons it could benefit from an early cycle recovery. Other firms have issued differing updates following Texas Instrumen…
Palladyne AI Corp. (NASDAQ:PDYN) saw its shares climb 13% after the Air Force Research Laboratory granted the company a contract named HANGTIME. The program will deploy Palladyne’s SwarmOS™ platform to connect autonomous systems across multiple domains, integrating satellites for the first time and aiming to enable faster, coordinated decision-maki…
Israel’s parliament moves to cast an initial vote on the 2026 state budget draft amid deepening rifts within Prime Minister Benjamin Netanyahu’s coalition. With the law requiring full approval by the end of March or a snap election being triggered, disputes over military conscription for ultra-Orthodox seminary students and sharp differences over w…
Eli Lilly has entered into a collaboration worth as much as $1.12 billion with Germany-based Seamless Therapeutics to develop and commercialize gene-editing therapies aimed at certain forms of hearing loss. The arrangement grants Lilly access to Seamless' proprietary enzyme platform, which engineers programmable recombinases designed to make large,…
UBS moved Intershop Holding AG (SIX:ISN) from a 'buy' to a 'neutral' rating while increasing its 12-month price target to CHF170. The brokerage says the stock's strong run has restored its valuation to historical norms, leaving scant upside from recent levels. UBS also trimmed revenue and adjusted EPS forecasts for fiscal 2025-27 and highlighted ti…
JFrog has re-established a credible growth narrative with recent results showing mid-20% revenue growth and outsized cloud strength, and the stock is coiling just under key moving averages after a major 2025 breakout. With a clean balance sheet (no debt-to-equity) and improving momentum signals, FROG offers a mid-term long trade setup into potentia…
ThriveCart will roll out ThrivePay Installments later on Wednesday, a feature that lets customers divide purchases into 3, 6, or 12 monthly payments by using available capacity on their existing credit cards rather than creating new loans. The company says the product targets both one-time digital and physical purchases as well as subscriptions, an…
UBS raised its price target on Texas Instruments (TXN) to $260 from $245 and kept a Buy rating, citing stronger revenue trends, improved bookings and constructive backlog commentary. UBS also designated TXN a Top Pick for 2026 and flagged rising free cash flow potential. The stock is trading near $196.63, while other analysts such as Mizuho have ad…
GE Vernova on Wednesday raised its revenue outlook for 2026 to a range of $44 billion to $45 billion, topping the average analyst estimate of $41.97 billion. The company reported a 34% jump in quarterly orders to $59.3 billion and saw sizable gains in core profits for its electrification and power segments, driven by rising demand from data centers…
UBS increased its price target for Boeing to $285 from $275 while maintaining a Buy rating, pointing to improving free cash flow and management's emphasis on quality and stability as production ramps. Boeing reported a robust fourth quarter with earnings and revenue that beat expectations, prompting several other analysts to raise their targets.
UBS raised its price objective on RTX to $208 from $199 while retaining a Neutral recommendation after the company reported strong fourth-quarter results. The investment bank pointed to better-than-expected free cash flow in 2025 and 2026 guidance, margin progress across RTX’s businesses and improvements in core cash generation despite higher capit…
UBS increased its 12-month price target on UPS to $125 from $116 while retaining a Buy recommendation, even as it reduced its Q1 earnings-per-share estimate because of near-term margin pressures. UBS and other analysts expect margin headwinds to ease through 2026, with a notable improvement anticipated in the domestic package business in the second…
UBS increased its price target on Nextpower (NXT) to $140 from $125 and kept a Buy rating, citing the company’s leading position in solar trackers, strong customer relationships and its shift toward a broader electric hardware platform. The upgrade follows robust quarterly results and additional positive analyst actions from JPMorgan and KeyBanc, r…
The dollar steadied on Wednesday following a steep decline to a four-year low overnight, a move that President Donald Trump publicly welcomed as the currency being "great" and that it should "just seek its own level." Markets are weighing whether the administration prefers a weaker dollar while Treasury Secretary Scott Bessent has remained tight-li…
On Jan. 28, Eikon Therapeutics filed to pursue a U.S. initial public offering that would value the company at as much as $908.2 million and raise up to $317.7 million by selling 17.65 million shares at $16 to $18 apiece. The Millbrae, California-based drug developer is advancing a cancer pipeline led by EIK1001, being evaluated in combination with …
On Jan 28 the FTSE 100 declined as losses in healthcare and bank shares offset gains in miners and energy names. The domestically focused FTSE 250 rose, hitting its highest level since January 2022 earlier in the session. Market attention centred on corporate earnings and an awaited U.S. Federal Reserve policy update.
